Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, February 09, 2026
Eurofins Viracor BioPharma Services announced a significant expansion of its service portfolio with the addition of enhanced bioanalytical testing capabilities.
read more
Thursday, February 05, 2026
The Coalition for Epidemic Preparedness Innovations (CEPI) and Samsung Biologics announced a partnership to strengthen vaccine manufacturing preparedness for future epidemic and pandemic threats.
read more
Wednesday, February 04, 2026
Lightship Inc. announced it has acquired Veda Trials, a company specializing in end to end clinical operations delivered in community care settings. The acquisition strengthens Lightship’s ability to meet participants where they are and accelerate ...
read more
Wednesday, February 04, 2026
Southern Research and London-based Pathogenus Consulting have signed a three-year partnership that will allow both organizations to capitalize on growing research opportunities around the world.
read more
Wednesday, February 04, 2026
The Seattle facility of AGC Biologics has received a Good Manufacturing Practices Certification from Agência Nacional de Vigilância Sanitária (Anvisa), Brazil’s health regulatory authority.
read more
Tuesday, February 03, 2026
Spruce Biosciences announced the appointments of Daven Mody, Pharm.D., as Senior Vice President of Regulatory and Quality and Bruno Gagnon, B.Pharm., M.Sc., as Senior Vice President, Clinical Development Operations.
read more
Tuesday, February 03, 2026
Bionique Testing Laboratories announced the appointment of Andy Bailey, PhD, as President and Chief Executive Officer, effective April 1, 2026.
read more
Tuesday, February 03, 2026
WuXi Biologics has signed a license and research service agreement with Vertex Pharmaceuticals for an innovative trispecific T-cell Engager (TCE) for the treatment of B-cell mediated autoimmune diseases.
read more
Monday, February 02, 2026
Piramal Pharma Solutions announced the successful development, scale-up, and commercialization of a tablet-in-capsule drug delivery system at its drug product facilities in Pithampur and Ahmedabad, India.
read more
Thursday, January 29, 2026
Ardena announced that it has completed the divestment of its drug substance (API) site in Södertälje, Sweden, to Nanologica AB.
read more
Thursday, January 29, 2026
REPROCELL announced the launch of StemEdit, its clinical gene editing services and new gene-edited iPSC product lines leveraging OpenCRISPR-1™, an AI-designed genome editing system licensed from Profluent.
read more
Thursday, January 29, 2026
Piramal Pharma Limited reported consolidated revenue from operations of ?2,140 crore for Q3 FY26, down 3% from ?2,204 crore in Q3 FY25, with 9M FY26 revenue declining 4% to ?6,117 crore from ?6,397 crore.
read more
Thursday, January 29, 2026
Vetter has confirmed its plans to build a state-of-the-art production facility in the Saarland region of southwest Germany.
read more
Thursday, January 29, 2026
Frontage Europe, a wholly owned subsidiary of Frontage Laboratories Inc., has relocated its bioanalytical laboratory to a new 2,500-square-meter facility near Milan, Italy.
read more
Thursday, January 29, 2026
WuXi Biologics and Sinorda Biomedicine announced a strategic collaboration for the development and manufacturing of SND006, a novel bispecific antibody, for the potential treatment of inflammatory bowel disease (IBD) and other autoimmune diseases.
read more